US Patent 7255866 Botulinum toxin therapy for fibromyalgia
Patent 7255866 was granted and assigned to Allergan, Inc. on August, 2007 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7255866 Botulinum toxin therapy for fibromyalgia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
